{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT04467983","recordId":"NCT04467983","peptideSlug":"abaloparatide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04467983-abaloparatide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct04467983.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct04467983.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2020-07-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-07-08","publishedAt":"2026-08-23","recordId":"NCT04467983","recordSha256":"cb110c7c67e46abeb6e821cbc431467ac72f0237737c116841855facb3e14ff7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04467983?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Sponsor/Collaborators","Study Description","Study Design","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2020-07-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-07-10","publishedAt":"2026-08-23","recordId":"NCT04467983","recordSha256":"f19968e40c8b9043f3af45bd64fcce1ed1e15455cfe68b7508f9612b042d916d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04467983?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Sponsor/Collaborators","Study Description","Study Identification","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2021-02-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2021-02-12","publishedAt":"2026-08-23","recordId":"NCT04467983","recordSha256":"2323b88d1cb69f7a6e0ca8806826e18ee49dcef9a9c43585229f05aae73c2239","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04467983?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Identification","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2024-06-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2024-06-14","publishedAt":"2026-08-23","recordId":"NCT04467983","recordSha256":"ba01c025bfd405aefe8030832aecf7e99cad598caa08365970671b414bf1fc35","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04467983?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2024-09-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2024-09-05","publishedAt":"2026-08-23","recordId":"NCT04467983","recordSha256":"14cd4cafe3fc31ac5f945d65a55356605183566b2f136fb07de73684e60367ff","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04467983?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Oversight","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2025-04-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2025-04-30","publishedAt":"2026-08-23","recordId":"NCT04467983","recordSha256":"c411ba0cf8bddeaa6b0eeedc80ab54127cbe4e7b011e30e499f2f2057230e551","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04467983?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Oversight","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2026-06-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2026-06-04","publishedAt":"2026-08-23","recordId":"NCT04467983","recordSha256":"71a9e7bff6cb23376bfd447fb329a8ff3f82c9623c75a0efd0cc631cff877b23","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04467983?a=7&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"478db72dbfe034f343310e7e952cca8965e731daa1f4c5c731053983bb738e6c"}}